valproate우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42492303
Valproate vs levetiracetam in juvenile myoclonic epilepsy: systematic review and meta-analysis.
Valproate vs levetiracetam in juvenile myoclonic epilepsy: systematic review and meta-analysis.
- 저자
- Lavínia Voss Agra, Marcela Caracas Machado Borges, Luiz Carlos Fonseca de Azevedo Oliveira, Isabela Montenegro Tenório de Carvalho, Júlia Agra Silva, Ana Beatriz P Aguiar-Barros
- 저널
- Epilepsy & behavior : E&B
- 공개일
- 2026 Jul 23
- 연구 유형
- 기타
- DOI
- 10.1016/j.yebeh.2026.111208
문헌 요약
Juvenile myoclonic epilepsy (JME) is a genetic generalized epilepsy syndrome with onset typically in adolescence and a chronic course requiring long-term antiseizure medications (ASMs). Valproate (VPA) is the most effective treatment for seizure control in JME but use is limited by metabolic, cognitive, and teratogenic adverse effects (AEs). Levetiracetam…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.